Abstract
Melanoma is one of the most aggressive and highly metastatic cancers. The most common sites of distant metastases are soft tissues, lung, liver, skin and brain, whereas only few patients develop gastrointestinal metastases. Metastatic involvement of the gallbladder is rare and more often part of a widespread disease than a solitary lesion. The “gold-standard” treatment of metastatic melanoma of the gallbladder remains unclear. We report two cases of patients with past history of cutaneous melanoma who developed visceral metastases. The first patient was asymptomatic and had a widespread disease with metastatic involvement of both the spleen and the gallbladder. The second patient had an isolated metastasis of the gallbladder and complained of upper abdominal pain. The chosen treatment was open cholecystectomy (and splenectomy) in the first case and laparoscopic cholecystectomy in the second. A review of the literature is provided.
Similar content being viewed by others
References
Miller AJ, Mihm MC. Melanoma. N Engl J Med. 2006;355:51–65.
Vernadakis S, Rallis G, Danias N, et al. Metastatic melanoma of the gallbladder: an unusual clinical presentation of acute cholecystitis. World J Gastroenterol. 2009;15:3434–6.
Furumoto K, Miyauchi Y, Ito D, Kitai T, Kogire M. Solitary metastatic gallbladder malignant melanoma originated from the nasal cavity: a case report. Int J Surg Case Rep. 2013;4:965–8.
Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 1996;131(975–979):979–80.
Gorantla V, Kirkwood JM, Tawbi HA. Melanoma brain metastases: an unmet challenge in the era of active therapy. Curr Oncol Rep. 2013;15:483–91.
Marone U, Caracò C, Losito S, et al. Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literature. World J Surg Oncol. 2007;5:141.
Crippa S, Bovo G, Romano F, Mussi C, Uggeri F. Melanoma metastatic to the gallbladder and small bowel: report of a case and review of the literature. Melanoma Res. 2004;14:427–30.
Samplaski MK, Rosato EL, Witkiewicz AK, Mastrangelo MJ, Berger AC. Malignant melanoma of the gallbladder: a report of two cases and review of the literature. J Gastrointest Surg. 2008;12:1123–6.
Gogas J, Mantas D, Gogas H, Kouskos E, Markopoulos C, Vgenopoulou S. Metastatic melanoma in the gallbladder: report of a case. Surg Today. 2003;33:135–7.
Breslow A. The surgical treatment of stage I cutaneous melanoma. Cancer Treat Rev. 1978;5:195–8.
Armstrong BK, Kricker A. Skin cancer. Dermatoepidemiology. 1995;13:583–90.
Office for National Statistics Cancer statistics registrations. Registrations of cancers diagnosed in 2002. London: MBI; 2005. p. 33.
Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–34.
Ollila DW. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer. 2011;117:4579–81.
Kainthla R, Kim KB, Falchook GS. Dabrafenib for treatment of BRAF-mutant melanoma. Pharmgenomics Pers Med. 2013;7:21–9.
Ostick DG, Haqqani MT. Obstructive cholecystitis due to metastatic melanoma. Postgrad Med J. 1976;52:710–2.
Onozawa H, Saito M, Yoshida S, et al. Multiple metastatic malignant melanoma presenting intraluminal gallbladder bleeding. Int Surg. 2014;99:600–5.
Henriques CQ. A case of secondary melanoma of the gall-bladder presenting as acute cholecystitis. Br J Surg. 1955;42:663–5.
McFadden PM, Krementz ET, McKinnon WM, Pararo LL, Ryan RF. Metastatic melanoma of the gallbladder. Cancer. 1979;44:1802–8.
Dong XD, DeMatos P, Prieto VG, Seigler HF. Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer. 1999;85:32–9.
Katz SC, Bowne WB, Wolchok JD, Busam KJ, Jaques DP, Coit DG. Surgical management of melanoma of the gallbladder: a report of 13 cases and review of the literature. Am J Surg. 2007;193:493–7.
Hatanaka N, Miyata M, Kamiike W, et al. Radical resection of primary malignant melanoma of the gallbladder with multiple metastases: report of a case. Surg Today. 1993;23:1023–6.
Martel JP, McLean CA, Rankin RN. Melanoma of the gallbladder. Radiographics. 2009;29:291–6.
Seelig MH, Schonleben K. Laparoscopic cholecystectomy for a metastasis of a malignant melanoma in the gallbladder. Z Gastroenterol. 1997;35:673–5.
Tuveri M, Tuveri A. Isolated metastatic melanoma to the gallbladder: is laparoscopic cholecystectomy indicated? A case report and review of the literature. Surg Laparosc Endosc Percutan Tech. 2007;17:141–4.
Kohler U, Jacobi T, Sebastian G, Nagel M. Laparoscopic cholecystectomy in isolated metastasis of malignant melanoma to the gallbladder. Chirurg. 2000;71:1517–20.
Varsamidakis N, Panagiotou P, Yettimis E. Isolated gallbladder metastatic melanoma. HPB (Oxford). 2006;8:73.
Christou D, Katodritis N, Decatris MP, et al. Melanoma of the gallbladder: appropriate surgical management and review of the literature. Clin Case Rep. 2014;2:313–8.
Batus M, Waheed S, Ruby C, Petersen L, Bines SD, Kaufman HL. Optimal management of metastatic melanoma: current strategies and future directions. Am J Clin Dermatol. 2013;14:179–94.
Tarhini AA, Kirkwood LM, Gooding WE, Cai C, Agarwala SS. Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. J Clin Oncol. 2007;25:3802–7.
Robert L, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364:2517–26.
Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–23.
Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16.
Schwartzentruber DJ, Lawson DH, Richards JM, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med. 2011;364:2119–27.
Robert C, Karaszewska B, Schachter J, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30–9.
Larkin J, Ascierto PA, Dréno B, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371:1867–76.
Long GV, Stroyakovskiy D, Gogas H, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med. 2014;371:1877–88.
Flaherty KT, Infante JR, Daud A, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694–703.
Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372:320–30.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giannini, I., Cutrignelli, D.A., Resta, L. et al. Metastatic melanoma of the gallbladder: report of two cases and a review of the literature. Clin Exp Med 16, 295–300 (2016). https://doi.org/10.1007/s10238-015-0353-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-015-0353-6